nach oben

Erschienen in:

01.10.2019 | Original Article

Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study

verfasst von: Hiroyuki Kiriyama, Hidehiro Kaneko, Hidetaka Itoh, Yuriko Yoshida, Koki Nakanishi, Yoshiko Mizuno, Masao Daimon, Hiroyuki Morita, Yutaka Yatomi, Issei Komuro

Erschienen in: Journal of Nephrology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Risk factors for renal function deterioration in the general population are not fully understood. We aimed to clarify the determinants of estimated glomerular filtration rate (eGFR) decline using a community-based cohort.

Methods and results

Among 3217 subjects who underwent repeated health check-ups, we excluded 478 subjects with eGFR ≤ 60 mL/min/1.73 m² and examined 2739 subjects. EGFR decline rate was calculated from the difference in eGFR between the first and last visits. EGFR decline, which was defined as a drop in GFR accompanied by a 25% or greater drop in eGFR from baseline and/or a sustained decline of more than 5 mL/min/1.73 m²/year, was observed in 209 subjects (7.6%). Anemia according to the WHO definition (16.7% vs. 11.7%, p = 0.03), and proteinuria (3.3% vs. 0.8%, p < 0.001) at baseline were more commonly observed in subjects with eGFR decline. Multivariable logistic regression analysis showed that anemia and proteinuria were independently associated with eGFR decline.

Conclusion

Anemia and proteinuria were closely related to eGFR decline, which suggests that we should consider these parameters as risk factors of the development of renal function deterioration even in the general population.

Nur mit Berechtigung zugänglich

Epstein M (1996) Aging and the kidney. J Am Soc Nephrol 7(8):1106–1122PubMed

Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ et al (2014) Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 311(24):2518–2531CrossRefPubMedCentralPubMed

Cheng TY, Wen SF, Astor BC, Tao XG, Samet JM, Wen CP (2008) Mortality risks for all causes and cardiovascular diseases and reduced GFR in a middle-aged working population in Taiwan. Am J Kidney Dis 52(6):1051–1060CrossRefPubMed

Van Pottelbergh G, Den Elzen WPJ, Degryse J, Gussekloo J (2013) Prediction of mortality and functional decline by changes in eGFR in the very elderly: the Leiden 85-plus study. BMC Geriatr 13:61CrossRefPubMedCentralPubMed

Rein P, Saely CH, Muendlein A, Vonbank A, Drexel H (2010) Serial decline of kidney function as a novel biomarker for the progression of atherothrombotic disease. Atherosclerosis 211(1):348–352CrossRefPubMed

Al-Aly Z, Zeringue A, Fu J, Rauchman MI, McDonald JR, El-Achkar TM et al (2010) Rate of kidney function decline associates with mortality. J Am Soc Nephrol 21(11):1961–1969CrossRefPubMedCentralPubMed

GuoY Cui L, Ye P, Li J, Wu S, Luo Y et al (2018) Change of kidney function is associated with all-cause mortality and cardiovascular diseases; results from kailuan study. JAHA 7:e010596. https://doi.org/10.1161/118.010596 CrossRef

Lee SC, Daimon M, Di Tullio MR, Homma S, Hasegawa T, Chiou SH et al (2018) Beneficial effect of body weight control on left ventricular diastolic function in the general population: an analysis of longitudinal data from a health check-up clinic. Eur Heart J Cardiovasc Imaging 19(2):136–142CrossRefPubMed

Blanc B, Finch CA, Hallberg L (1968) Nutritional anemias report of a WHO scientific group. WHO Tech Rep Ser 405:1–40

10.

Kaneko H, Neuss M, Okamoto M, Weissenborn J, Butter C (2018) Impact of preprocedural anemia on outcomes of patients with mitral regurgitation who underwent mitraclip implantation. Am J Cardiol 122(5):859–865CrossRefPubMed

11.

Lamb EJ, MacKenzie F, Stevens PE (2009) How should proteinuria be detected and measured? Ann Clin Biochem 46:205–217CrossRefPubMed

12.

Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K et al (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53(6):982–992CrossRefPubMed

13.

Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA et al (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63(5):713–735CrossRefPubMed

14.

Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL et al (2003) Kidney disease as a risk factor for development of cardiovascular disease—a statement from the American Heart Association councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation 108(17):2154–2169CrossRefPubMed

15.

Go AS, Chertow GM, Fan DJ, McCulloch CE, Hsu CY (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. New Engl J Med 351(13):1296–1305CrossRefPubMed

16.

Kovesdy CP, Trivedi BK, Anderson JE (2006) Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study. Adv Chronic Kidney Dis 13(2):183–188CrossRefPubMed

17.

Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF et al (2013) Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet (Lond, Engl) 382(9889):339–352CrossRef

18.

Turin TC, James M, Ravani P, Tonelli M, Manns BJ, Quinn R et al (2013) Proteinuria and rate of change in kidney function in a community-based population. J Am Soc Nephrol 24(10):1661–1667CrossRefPubMedCentralPubMed

19.

Rosansky SJ, Hoover DR, King L, Gibson J (1990) The association of blood pressure levels and change in renal function in hypertensive and nonhypertensive subjects. Arch Intern Med 150(10):2073–2076CrossRefPubMed

20.

Hemmelgarn BR, Zhang J, Manns BJ, Tonelli M, Larsen E, Ghali WA et al (2006) Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int 69(12):2155–2161CrossRefPubMed

21.

Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW et al (1994) The effects of dietary-protein restriction and blood-pressure control on the progression of chronic renal-disease. New Engl J Med 330(13):877–884CrossRefPubMed

22.

Ikeda N, Saito E, Kondo N, Inoue M, Ikeda S, Satoh T et al (2011) Japan: universal health care at 50 years 1 What has made the population of Japan healthy? Lancet (Lond, Engl) 378(9796):1094–1105CrossRef

23.

Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS (2009) Risk factors for end-stage renal disease 25-year follow-up. Arch Intern Med 169(4):342–350CrossRefPubMedCentralPubMed

24.

Iseki K, Ikemiya Y, Iseki C, Takishita S (2003) Hematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transpl 18(5):899–905CrossRef

25.

Chang WX, Arai S, Tamura Y, Kumagai T, Ota T, Shibata S et al (2016) Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol 20(1):58–70CrossRefPubMed

26.

Semama D, Heumann C, Guignard JP (1995) Protection from hypoxemic renal dysfunction by verapamil and manganese in the rabbit. Life Sci 56(4):231–239CrossRefPubMed

27.

Pozzoli S, Simonini M, Manunta P (2018) Predicting acute kidney injury: current status and future challenges. J Nephrol 31(2):209–223CrossRefPubMed

28.

Levey AS, de Jong PE, Coresh J, El Nahas M, Astor BC, Matsushita K et al (2011) The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int 80(1):17–28CrossRefPubMed

29.

Gansevoort RT, Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80(1):93–104CrossRefPubMedCentralPubMed

30.

Imai E, Horio M, Yamagata K, Iseki K, Hara S, Ura N et al (2008) Slower decline of glomerular filtration rate in the Japanese general population: a longitudinal 10-year follow-up study. Hypertens Res 31(3):433–441CrossRefPubMed

Titel: Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study
verfasst von: Hiroyuki Kiriyama
Hidehiro Kaneko
Hidetaka Itoh
Yuriko Yoshida
Koki Nakanishi
Yoshiko Mizuno
Masao Daimon
Hiroyuki Morita
Yutaka Yatomi
Issei Komuro
Publikationsdatum: 01.10.2019
Verlag: Springer International Publishing
Erschienen in: Journal of Nephrology / Ausgabe 5/2019
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI: https://doi.org/10.1007/s40620-019-00605-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Role of anemia and proteinuria in the development of subsequent renal function deterioration in a general population with preserved glomerular filtration rate: a community-based cohort study